Dr Reddy’s launches anti-depressant generic in US

G Naga Sridhar Hyderabad | Updated on January 10, 2018 Published on September 06, 2017


Dr Reddy’s Laboratories Ltd has launched Bupropion Hydrochloride Extended-Release Tablets a therapeutic equivalent generic version of Wellbutrin XL (Bupropion Hydrochloride Extended-Release) tablets in the US market.

According to a release issued by the Hyderabad-based company here on Wednesday, the Wellbutrin XL brand and generic had US sales of approximately $754 million for the most recent twelve months ending in July 2017 according to IMS Health. Wellbutrin XL is a trademark of GlaxoSmithKline LLC.

Dr Reddy’s scrip lost 0.70 per cent and was trading at Rs 2,193.05 on the Bombay Stock Exchange on Wednesday

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on September 06, 2017
This article is closed for comments.
Please Email the Editor